Wockhardt Limited — Press Release

Wockhardt Limited has released its unaudited financial results for the quarter ended June 30, 2026. The company has submitted this regulatory filing to the stock exchanges, detailing its performance across both standalone and consolidated operations. This disclosure provides an early look at the company's financial health before the official audit is completed.

For investors, this update offers a crucial snapshot of the company's operational momentum and financial trajectory. It highlights the current performance of Wockhardt's pharmaceutical business, allowing shareholders to gauge progress against previous periods. This information is essential for assessing the company's current standing and future growth potential.

Investors should closely monitor the key financial metrics within the report, such as revenue growth and profit margins, to understand the company's operational efficiency. Keeping an eye on the company's future guidance and upcoming official audited results will provide a more complete picture of its long-term performance.